Skip to main content
Log in

Association of pericoronary adipose tissue with atrial fibrillation recurrence after ablation based on computed tomographic angiography

  • Original Article
  • Published:
Japanese Journal of Radiology Aims and scope Submit manuscript

Abstract

Purpose

Quantitative measurement of pericoronary adipose tissue volume (PCATV) and fat attenuation index (FAI) has mostly been used in the study of coronary artery related diseases but rarely in the relationship with atrial fibrillation (AF). This study was conducted to investigate the correlation of PCATV and FAI with the AF recurrence after ablation and the clinical significance.

Materials and methods

Patients with continuous AF who underwent radiofrequency ablation and computed tomographic angiography (CTA) were retrospectively enrolled. The PCATV, FAI, epicardial adipose tissue volume (EATV) and EAT density (EATD) arround the three main branches of the coronary arteries (LAD, LCX, and RCA) were measured quantitatively with cardiac function software and analyzed.

Results

189 patients with continuous AF who underwent radiofrequency ablation for the first time were enrolled. After 12-month follow-up with a mean follow-up time of 10.93 ± 0.16 months, 47 (24.9%) patients were confirmed to have AF recurrence. The 3 V-FAI (− 81.17 ± 4.27 vs. − 83.31 ± 4.59 HU, P = 0.005), LCX-FAI (median − 77 vs. median − 81HU, P < 0.001), EATV (median 141.14vs. median 125.39 ml, P = 0.010), and EATVI (median 70.77 vs. 66.73 ml/m2, P = 0.008) were significantly increased in the recurrence group. EATVI (OR 1.043, 95% CI 1.020–1.066) and LCX-FAI (OR 1.254, 95% CI 1.145–1.374) were two significant independent risk factors for AF recurrence. In the comparison of ROC, the predictive value of LCX-FAI (cut-off value of >− 81.5 HU, area under the curve (AUC) of 0.722) was higher than that of EATVI (cut-off value > 81.07 ml/m2, AUC of 0.630).

Conclusion

EATVI and LCX-FAI were related to recurrence of AF after ablation and have important clinical value in predicting the AF recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Zhang Z, et al. Associations of anemia with death and major bleeding in patients with atrial fibrillation: a report from the Chinese atrial fibrillation registry study. Clin Cardiol. 2022;45(1):91–100.

    Article  PubMed  Google Scholar 

  2. Vinding NE, et al. Ischemic stroke severity and mortality in patients with and without atrial fibrillation. J Am Heart Assoc. 2022;11(4): e022638.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Kany S, et al. Outcomes in patients experiencing complications associated with atrial fibrillation ablation: data from the German ablation registry. Int J Cardiol. 2022;363:64–70.

    Article  PubMed  Google Scholar 

  4. Oka T, et al. Post-ablation left atrial function impacts long-term recurrence of atrial fibrillation after ablation. Heart Vessels. 2022;37(2):315–26.

    Article  PubMed  Google Scholar 

  5. Rattanawong P, et al. Surgical versus catheter ablation in atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. J Cardiovasc Electrophysiol. 2022;33(10):2152–63.

    Article  PubMed  Google Scholar 

  6. Benjamin MM, et al. Association of left atrial strain by cardiovascular magnetic resonance with recurrence of atrial fibrillation following catheter ablation. J Cardiovasc Magn Reson. 2022;24(1):3.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Huber AT, et al. The relationship between enhancing left atrial adipose tissue at CT and recurrent atrial fibrillation. Radiology. 2022;305(1):56–65.

    Article  PubMed  Google Scholar 

  8. Simon J, et al. Left atrial appendage size is a marker of atrial fibrillation recurrence after radiofrequency catheter ablation in patients with persistent atrial fibrillation. Clin Cardiol. 2022;45(3):273–81.

    Article  PubMed  Google Scholar 

  9. O’Neill L, et al. Clinical, electrophysiological and imaging predictors of atrial fibrillation ablation outcome. Expert Rev Cardiovasc Ther. 2017;15(4):289–305.

    Article  CAS  PubMed  Google Scholar 

  10. Wong CX, et al. Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J Am Coll Cardiol. 2011;57(17):1745–51.

    Article  PubMed  Google Scholar 

  11. Tsao HM, et al. Quantitative analysis of quantity and distribution of epicardial adipose tissue surrounding the left atrium in patients with atrial fibrillation and effect of recurrence after ablation. Am J Cardiol. 2011;107(10):1498–503.

    Article  PubMed  Google Scholar 

  12. Nagashima K, et al. Association between epicardial adipose tissue volumes on 3-dimensional reconstructed CT images and recurrence of atrial fibrillation after catheter ablation. Circ J. 2011;75(11):2559–65.

    Article  CAS  PubMed  Google Scholar 

  13. Kocyigit D, et al. Periatrial epicardial adipose tissue thickness is an independent predictor of atrial fibrillation recurrence after cryoballoon-based pulmonary vein isolation. J Cardiovasc Comput Tomogr. 2015;9(4):295–302.

    Article  PubMed  Google Scholar 

  14. Goeller M, et al. Pericoronary adipose tissue CT attenuation and its association with serum levels of atherosclerosis-relevant inflammatory mediators, coronary calcification and major adverse cardiac events. J Cardiovasc Comput Tomogr. 2021;15(5):449–54.

    Article  PubMed  Google Scholar 

  15. Yuvaraj J, et al. Pericoronary adipose tissue attenuation is associated with high-risk plaque and subsequent acute coronary syndrome in patients with stable coronary artery disease. Cells. 2021;10(5):1143.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Hendriks JM, Heidbuchel H. The management of atrial fibrillation: an integrated team approach - insights of the 2016 European Society of Cardiology guidelines for the management of atrial fibrillation for nurses and allied health professionals. Eur J Cardiovasc Nurs. 2019;18(2):88–95.

    Article  PubMed  Google Scholar 

  17. Dai X, et al. Perivascular fat attenuation index and high-risk plaque features evaluated by coronary CT angiography: relationship with serum inflammatory marker level. Int J Cardiovasc Imaging. 2020;36(4):723–30.

    Article  PubMed  Google Scholar 

  18. Yu W, et al. Incremental value of epicardial fat volume to coronary artery calcium score and traditional risk factors for predicting myocardial ischemia in patients with suspected coronary artery disease. J Nucl Cardiol. 2022;29(4):1583–92.

    Article  PubMed  Google Scholar 

  19. Gorter PM, et al. Quantification of epicardial and peri-coronary fat using cardiac computed tomography; reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery disease. Atherosclerosis. 2008;197(2):896–903.

    Article  CAS  PubMed  Google Scholar 

  20. Oikonomou EK, et al. Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data. Lancet. 2018;392(10151):929–39.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Qin B, et al. The predictive value of the perivascular adipose tissue CT fat attenuation index for coronary in-stent restenosis. Front Cardiovasc Med. 2022;9: 822308.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. You D, et al. The correlation of pericoronary adipose tissue with coronary artery disease and left ventricular function. BMC Cardiovasc Disord. 2022;22(1):398.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Sun JT, et al. Pericoronary fat attenuation index is associated with vulnerable plaque components and local immune-inflammatory activation in patients with non-ST elevation acute coronary syndrome. J Am Heart Assoc. 2022;11(2): e022879.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Hu YF, et al. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015;12(4):230–43.

    Article  CAS  PubMed  Google Scholar 

  25. Park HW, et al. Neural mechanisms of atrial fibrillation. Curr Opin Cardiol. 2012;27(1):24–8.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Li B, et al. Pulmonary vein parameters are similar or better predictors than left atrial diameter for paroxysmal atrial fibrillation after cryoablation. Braz J Med Biol Res. 2019;52(9): e8446.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Schwartzman D, Lacomis J, Wigginton W. Characterization of left atrium and distal pulmonary vein morphology using multidimensional computed tomography. J Am Coll Cardiol. 2003;41(8):1349–57.

    Article  PubMed  Google Scholar 

  28. Girerd N, et al. Periatrial epicardial fat is associated with markers of endothelial dysfunction in patients with atrial fibrillation. PLoS ONE. 2013;8(10): e77167.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Nogami K, et al. Association between pericoronary adipose tissue attenuation and outcome after second-generation cryoballoon ablation for atrial fibrillation. Brit J Radiol. 2021;94:20210361.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Lang RM, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233–70.

    Article  PubMed  Google Scholar 

  31. Mahajan R, Lau DH, Sanders P. Impact of obesity on cardiac metabolism, fibrosis, and function. Trends Cardiovasc Med. 2015;25(2):119–26.

    Article  CAS  PubMed  Google Scholar 

  32. Mahajan R, et al. Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity. J Am Coll Cardiol. 2015;66(1):1–11.

    Article  CAS  PubMed  Google Scholar 

  33. Maurovich-Horvat P, et al. Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography. Int J Obes (Lond). 2007;31(3):500–6.

    Article  CAS  PubMed  Google Scholar 

  34. Antonopoulos AS, et al. Detecting human coronary inflammation by imaging perivascular fat. Sci Transl Med. 2017. https://doi.org/10.1126/scitranslmed.aal2658.

    Article  PubMed  Google Scholar 

  35. Gaborit B, et al. Human epicardial adipose tissue has a specific transcriptomic signature depending on its anatomical peri-atrial, peri-ventricular, or peri-coronary location. Cardiovasc Res. 2015;108(1):62–73.

    Article  CAS  PubMed  Google Scholar 

  36. Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med. 2005;2(10):536–43.

    Article  PubMed  Google Scholar 

  37. Hannukainen JC, et al. Reversibility of myocardial metabolism and remodelling in morbidly obese patients 6 months after bariatric surgery. Diabetes Obes Metab. 2018;20(4):963–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Wong CX, et al. Associations of epicardial, abdominal, and overall adiposity with atrial fibrillation. Circ Arrhythm Electrophysiol. 2016. https://doi.org/10.1161/CIRCEP.116.004378.

    Article  PubMed  Google Scholar 

  39. Oba K, et al. Effect of the epicardial adipose tissue volume on the prevalence of paroxysmal and persistent atrial fibrillation. Circ J. 2018;82(7):1778–87.

    Article  CAS  PubMed  Google Scholar 

  40. Maeda M, et al. Usefulness of epicardial adipose tissue volume to predict recurrent atrial fibrillation after radiofrequency catheter ablation. Am J Cardiol. 2018;122(10):1694–700.

    Article  PubMed  Google Scholar 

  41. Mazurek T, et al. Relation of proinflammatory activity of epicardial adipose tissue to the occurrence of atrial fibrillation. Am J Cardiol. 2014;113(9):1505–8.

    Article  PubMed  Google Scholar 

  42. Kim HW, Belin de Chantemèle EJ, Weintraub NL. Perivascular adipocytes in vascular disease. Arterioscler Thromb Vasc Biol. 2019;39(11):2220–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Fitzgibbons TP, Czech MP. Epicardial and perivascular adipose tissues and their influence on cardiovascular disease: basic mechanisms and clinical associations. J Am Heart Assoc. 2014;3(2): e000582.

    Article  PubMed  PubMed Central  Google Scholar 

  44. El Mahdiui M, et al. Posterior left atrial adipose tissue attenuation assessed by computed tomography and recurrence of atrial fibrillation after catheter ablation. Circ Arrhythm Electrophysiol. 2021;14(4): e009135.

    Article  PubMed  Google Scholar 

  45. Ciuffo L, et al. Periatrial fat quality predicts atrial fibrillation ablation outcome. Circ Cardiovasc Imaging. 2019;12(6): e008764.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cai-Ying Li.

Ethics declarations

Conflict of interest

The authors declared that they have no conflict of interest in publication of this article.

Ethical approval

This study was approved by the Ethic Committee of The Second Hospital of Hebei Medical University, and all data have been approved to be published by the journal.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ma, Gj., Guo, Fq., Hu, J. et al. Association of pericoronary adipose tissue with atrial fibrillation recurrence after ablation based on computed tomographic angiography. Jpn J Radiol 41, 955–964 (2023). https://doi.org/10.1007/s11604-023-01426-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11604-023-01426-x

Keywords

Navigation